Abstract:Plasmodium parasites cause malaria, a global health disease that is responsible for more than 200 million clinical cases and 600 000 deaths each year. Most deaths are caused by various complications, including malaria-associated acute respiratory distress syndrome (MA-ARDS). Despite the very rapid and efficient killing of parasites with antimalarial drugs, 15% of patients with complicated malaria succumb. This stresses the importance of investigating resolution mechanisms that are involved in the recovery from these complications once the parasite is killed. To study the resolution of MA-ARDS, P . berghei NK65-infected C57BL/6 mice were treated with antimalarial drugs after onset of symptoms, resulting in 80% survival. Micro-computed tomography revealed alterations of the lungs upon infection, with an increase in total and non-aerated lung volume due to edema. Whole body plethysmography confirmed a drastically altered lung ventilation, which was restored during resolution. Single-cell RNA sequencing indicated an increased inflammatory state in the lungs upon infection, which was accompanied by a drastic decrease in endothelial cells, consistent with CD8 + T cell mediated killing. During resolution, anti-inflammatory pathways were upregulated and proliferation of endothelial cells was observed. MultiNicheNet interactome analysis identified important changes in the ligand-receptor interactions during disease resolution that warrant further exploration in order to develop new therapeutic strategies. In conclusion, our study provides insights in pro-resolving pathways that limit inflammation and promote endothelial cell proliferation in experimental MA-ARDS. This information may be useful for the design of adjunctive treatments to enhance resolution after Plasmodium parasite killing by antimalarial drugs. Malaria is a global disease caused by Plasmodium parasites, resulting each year in more than 600 000 deaths, mainly caused by complications. Despite rapidly acting antimalarial drugs, 15% of patients who developed a complication still die. Therefore, we aimed to investigate the recovery from a malaria complication, namely malaria-associated acute respiratory distress syndrome (MA-ARDS), after parasite killing with antimalarial drugs. In our mouse model, lung alterations were observed upon infection and lung ventilation was restored during the recovery phase. Moreover, an increased inflammatory state in the lungs was observed upon infection, which was accompanied by a drastic decrease in number of endothelial cells. During resolution, anti-inflammatory pathways were upregulated and remaining endothelial cells multiplied to restore the blood vessel wall. Therefore, promotion of resolution and proliferation of endothelial cells may be an interesting approach to design novel treatments that can be used in combination with the antimalarial drugs.

Aspecific binding of anti-NK1.1 antibodies on myeloid cells in an experimental model for malaria-associated acute respiratory distress syndrome

PD-1 Expression on NK Cells in Malaria-Exposed Individuals is Associated with Diminished Natural Cytotoxicity and Enhanced Antibody-Dependent Cellular Cytotoxicity

NK cells contribute to the resolution of experimental malaria-associated acute respiratory distress syndrome after antimalarial treatment

Atypical B Cells Up-Regulate Costimulatory Molecules During Malaria and Secrete Antibodies with T Follicular Helper Cell Support

Atypical B cells upregulate co-stimulatory molecules during malaria and secrete antibodies with T follicular helper cell support

Single cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria

Phenotype and function of IL-10 producing NK cells in individuals with malaria experience.

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia

NK1.1 Expression Defines a Population of CD4+ Effector T Cells Displaying Th1 and Tfh Cell Properties That Support Early Antibody Production During Plasmodium yoelii Infection

Innate immunity to malaria—The role of monocytes

NK T cells promote IL-21 secretion and enhance Ab production and affinity maturation during Plasmodium yoelii infection

NK cell-induced damage to P.falciparum-infected erythrocytes requires ligand-specific recognition and releases parasitophorous vacuoles that are phagocytosed by monocytes in the presence of immune IgG

Neutrophils in malaria: The good, the bad or the ugly?

Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria

Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation

Essential role of extrathymic T cells in protection against malaria

Natural Killer Cell Behavior in Lymph Nodes Revealed by Static and Real-Time Imaging

Cytokines and Chemokines in Cerebral Malaria Pathogenesis

High IFN-gamma and TNF production by peripheral NK cells of Colombian patients with different clinical presentation of Plasmodium falciparum